BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Treatment
40 results:

  • 1. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
    Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
    Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-jak2-STAT3 axis.
    Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
    J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
    Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
    Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
    Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
    J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Mebendazole Impedes the Proliferation and Migration of pancreatic cancer Cells through SK1 Inhibition Dependent Pathway.
    Limbu KR; Chhetri RB; Oh YS; Baek DJ; Park EY
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500220
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in pancreatic cancer.
    Wang Y; Zheng K; Xiong H; Huang Y; Chen X; Zhou Y; Qin W; Su J; Chen R; Qiu H; Yuan X; Wang Y; Zou Y
    Front Immunol; 2021; 12():762989. PubMed ID: 34975854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling.
    Xiao Y; Liu Y; Gao Z; Li X; Weng M; Shi C; Wang C; Sun L
    Aging (Albany NY); 2021 Nov; 13(22):24753-24767. PubMed ID: 34821587
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of jak2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
    Fan X; Fu H; Xie N; Guo H; Fu T; Shan Y
    Aging (Albany NY); 2021 Oct; 13(19):22830-22842. PubMed ID: 34623971
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
    Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
    J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53.
    Liu X; Zhang L; Thu PM; Min W; Yang P; Li J; Li P; Xu X
    Sci China Life Sci; 2021 Aug; 64(8):1295-1310. PubMed ID: 33165811
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
    Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
    J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Glycochenodeoxycholate promotes the metastasis of gallbladder cancer cells by inducing epithelial to mesenchymal transition via activation of SOCS3/jak2/STAT3 signaling pathway.
    Wang H; Zhan M; Liu Q; Wang J
    J Cell Physiol; 2020 Feb; 235(2):1615-1623. PubMed ID: 31347168
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dracorhodin perchlorate induces apoptosis and G2/M cell cycle arrest in human esophageal squamous cell carcinoma through inhibition of the jak2/STAT3 and AKT/FOXO3a pathways.
    Lu Z; Lu C; Li C; Jiao Y; Li Y; Zhang G
    Mol Med Rep; 2019 Sep; 20(3):2091-2100. PubMed ID: 31322237
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through jak2/STAT3 pathway.
    Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma.
    Dong Z; Zhang L; Xu W; Zhang G
    Mol Med Rep; 2018 Oct; 18(4):3769-3779. PubMed ID: 30106102
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anticancer effect of SZC015 on pancreatic cancer via mitochondria-dependent apoptosis and the constitutive suppression of activated nuclear factor κB and STAT3 in vitro and in vivo.
    Song Y; Gao L; Tang Z; Li H; Sun B; Chu P; Qaed E; Ma X; Peng J; Wang S; Hu M; Tang Z
    J Cell Physiol; 2018 Jan; 234(1):777-788. PubMed ID: 30078206
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Momelotinib therapy for myelofibrosis: a 7-year follow-up.
    Tefferi A; Barraco D; Lasho TL; Shah S; Begna KH; Al-Kali A; Hogan WJ; Litzow MR; Hanson CA; Ketterling RP; Gangat N; Pardanani A
    Blood Cancer J; 2018 Mar; 8(3):29. PubMed ID: 29515114
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/jak2/STAT3 signaling.
    Zhang X; Lu H; Hong W; Liu L; Wang S; Zhou M; Chen B; Bai Y
    Oncol Rep; 2018 Apr; 39(4):1892-1900. PubMed ID: 29393444
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.